Among these, GM-CSF has been widely studied and has shown promising anti-tumor results in many tumor models, such as melanoma cells[2], bladder cancer cells[3], murine leukemia[4], etc. GVAX (Cell Genesys) is a tumor vaccine comprised of genetically modified tumor cells engineered to secrete GM-CSF. This evidence concerns the gene CSF2 and urinary bladder cancer.